ElixirTrials — Decentralized Clinical Trials for Community Hospitals

News We're out of stealth. Read the release

Someone you love
may need a clinical trial.
Today, 88% of hospitals
can't run trials.

That's not a gap. It's a wall.

Stylized illustration representing failed clinical trial enrollment.

80% of trials fail to meet
enrollment targets.

Stylized illustration representing financial cost of trial delays.

$8M lost per day
when trials are delayed.

Stylized illustration representing community hospitals without trial infrastructure.

88% of U.S. hospitals
lack infrastructure
to run clinical trials.

For most patients,
clinical trials are out of reach.

Maria drove 4 hours each way.
Twice a week. For six months.
Then she stopped.
Not because she chose to.
Because the system made it impossible.

The trial lost a patient. Science lost a data point. Maria's disease didn't wait.

Maria didn't fail.
The trial didn't fail.
The system failed.

It's time to fix the broken system. Clinical trial access for all is now a reality.

Trials belong
where patients live.

The trial comes to the patient. Not the other way around. That's the magic of ElixirTrials.

For sites

You treat
the patients.

  • Zero upfront cost to site.
  • 100% of trial revenue retained by site.
  • Turnkey infrastructure and staffing support.
  • AI-powered workflow.
  • Access to a steady pipeline of clinical trials.
  • New revenue stream and elevated standard of care.
Talk to us
Diagram: ElixirTrials connects sites, patients, and sponsors in one network.

For pharma

You bring
the science.

  • Unlock access to unreachable patients at scale.
  • Accelerated enrollment across a unified network.
  • Scaled access to diverse, underrepresented patients.
  • One contract, one network, simplified execution.
  • Standardized, regulatory-grade data across all sites.
  • Rapid study start-up with pre-enabled infrastructure.
  • Predictable delivery through centralized operations.
Talk to us
Rebuilding clinical trials around the patient.

Rebuilding clinical trials
around patients.

New sites. More patients. High-quality data.

Cauldron — ElixirTrials' clinical trial operations platform.

Cauldron — Clinical Trial OS

The humans make
the decisions.
The AI does the busy work.

Scheduling, documentation, compliance, reporting. All clinical trial workflows. Handled.

Heather Grey

Heather Grey

CEO

  • 15+ years building and scaling clinical trial businesses.
  • Former Tempus TIME Trial builder.
  • Led large scale pharma partnerships.
  • Global leader of clinical trial and Real World Data teams.
Noah Dolev

Noah Dolev

PhD, CTO

  • PHD, Computational Neuroscience.
  • 15+ years building AI products.
  • 6 startups, 2 unicorns (Wix, Gong Alumnus).

Newsroom

The latest
from ElixirTrials.

July 20, 2026

ElixirTrials Emerges from Stealth to Build the Infrastructure Needed to Bring Clinical Trials to Every Community

Read the release

All press releases

ElixirTrials

Trials belong
where patients live.

ElixirTrials operates as a network of site-centric clinical trial operations designed to expand clinical trial access to underserved and geographically distributed patient populations. All participating hospital sites undergo formal feasibility assessment, regulatory documentation review, and protocol-specific staff training prior to site initiation.

Data collection, patient safety monitoring, and adverse event reporting are conducted in accordance with 21 CFR Part 11 and applicable Good Clinical Practice standards. ElixirTrials maintains full audit trail capability across all site activities via the Cauldron platform.

ElixirTrials is an integrated research organization operating in compliance with ICH-GCP guidelines and applicable FDA and EMA regulations. All trial activities are conducted under institutional review board (IRB) oversight.

Cauldron is a proprietary clinical trial management platform developed by ElixirTrials Inc. Site partnerships are subject to executed master service agreements.

Newsroom

Privacy Policy

ElixirTrials

ElixirTrials

Trials belong
where patients live.

ElixirTrials operates as a network of site-centric clinical trial operations designed to expand clinical trial access to underserved and geographically distributed patient populations. All participating hospital sites undergo formal feasibility assessment, regulatory documentation review, and protocol-specific staff training prior to site initiation.

Data collection, patient safety monitoring, and adverse event reporting are conducted in accordance with 21 CFR Part 11 and applicable Good Clinical Practice standards. ElixirTrials maintains full audit trail capability across all site activities via the Cauldron platform.

ElixirTrials is an integrated research organization operating in compliance with ICH-GCP guidelines and applicable FDA and EMA regulations. All trial activities are conducted under institutional review board (IRB) oversight.

Cauldron is a proprietary clinical trial management platform developed by ElixirTrials Inc. Site partnerships are subject to executed master service agreements.

Newsroom

Privacy Policy